U.S. Markets closed

Nautilus Biotechnology, Inc. (NAUT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.22-0.18 (-1.91%)
At close: 4:00PM EDT
9.20 -0.02 (-0.22%)
After hours: 05:35PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close9.40
Open9.35
Bid8.95 x 1100
Ask9.40 x 800
Day's Range8.85 - 9.35
52 Week Range8.85 - 25.89
Volume248,750
Avg. Volume149,896
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Nautilus Biotechnology Appoints Emma Lundberg, Ph.D., to Scientific Advisory Board
    GlobeNewswire

    Nautilus Biotechnology Appoints Emma Lundberg, Ph.D., to Scientific Advisory Board

    Human Protein Atlas director and spatial proteomics pioneer brings deep expertise in human cell biology, bioimaging, and artificial intelligence to company seeking to comprehensively quantify the proteome Emma Lundberg, Ph.D. Nautilus Biotechnology Scientific Advisory Board Member SEATTLE, June 17, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the